{"id":"W2598488323","doi":"10.1200/jco.2012.30.15_suppl.2051","title":"Phase II study of PX-866 in recurrent glioblastoma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; University of Toronto; Dalhousie University; Queen's University; Cancer Care Ontario; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; Queen Elizabeth II Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; PTEN; Oncology; Phases of clinical research; Clinical endpoint; Interim analysis; Clinical trial; Gastroenterology; Surgery; Chemotherapy; PI3K/AKT/mTOR pathway; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001520006,0.001893197,0.001998645,0.0006341409,0.0003425108,0.0006715127,0.000919361,0.001208227,0.004632758],"category_scores_gemma":[0.0005659088,0.0006145742,0.001023561,0.0004500862,0.0006768926,0.0005068444,0.0004761406,0.002153215,0.001683637],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006714615,"about_ca_system_score_gemma":0.001665563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001125046,"about_ca_topic_score_gemma":0.002018594,"domain_scores_codex":[0.9995424,0.0002111598,0.0000303231,0.00005727814,0.00004775469,0.0001111835],"domain_scores_gemma":[0.9995783,0.00004512056,0.00009204392,0.00004279175,0.00003706829,0.0002047103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6693891,0.09235112,0.008779063,0.001875295,0.00129752,0.0006511908,0.0004733125,0.003784227,0.06992212,0.0005146686,0.00780402,0.1431583],"study_design_scores_gemma":[0.2752323,0.7035515,0.01050732,0.00004273061,0.0003418986,0.0005626149,0.00005518131,0.001216141,0.005723761,0.0001562054,0.002584189,0.00002632994],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991311,0.001640517,0.000589737,0.0002988063,0.0001208906,0.003211329,0.00126336,0.0001472131,0.001417248],"genre_scores_gemma":[0.9810445,0.002005552,0.002033177,0.0008097499,0.0001645559,0.004049472,0.005283948,0.00004596966,0.004563178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004632758,"threshold_uncertainty_score":0.01549816,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1707776804509126,"score_gpt":0.5325706223306893,"score_spread":0.3617929418797767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}